Area Development
Adesis, Inc., a leading contract research organization and a wholly-owned subsidiary of Universal Display Corporation, is expanding with a new state-of-the-art laboratory in Wilmington, Delaware.

According to company officials, the expanded lab space approximately triples Adesis’ footprint in the DuPont Experimental Station, and will support its growing research and development pipeline.

“The new lab expansion in the Experimental Station increases our research footprint and broadens our capabilities for discovering, developing and designing critical chemistry solutions,” said Andrew Cottone, Ph.D., President of Adesis, Inc. “For nearly a century, the DuPont site has contributed to Delaware’s reputation as a leader in chemical research and development, and we are proud that Adesis is part of that remarkable legacy.”

As a wholly-owned subsidiary of Universal Display Corporation, Adesis is a contract research organization supporting the pharma, biotech, catalysis and a number of other industries. The CRO specializes in organic and organometallic synthesis, in milligrams to multi-kilogram quantities. Adesis has a business model of providing clients with organic chemistry services in three areas: early stage research, scale up and development, and specialty manufacturing.

“Supporting Adesis’ growth in Delaware has been very gratifying for the DPP team to be a part of. As a leading chemical contract research manufacturing and R&D organization, Adesis plays an important role in enhancing Delaware’s vibrant science sector,” said Kurt Foreman, President and CEO of Delaware Prosperity Partnership. “Andrew Cottone and his team are doing great work. We look forward to celebrating Adesis’ continued growth.”

The Adesis team said it worked closely with the office of Governor John Carney and Delaware Prosperity Partnership (DPP), who were integral in facilitating the search and securing the Experimental Station agreement.